<i>PTPRG</i> is an ischemia risk locus essential for HCO<sub>3</sub><sup>-</sup>-dependent regulation of endothelial function and tissue perfusion.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32955439.
- Also identified by DOI 10.7554/eLife.57553 and PMC identifier 7541084.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Acid-base conditions modify artery tone and tissue perfusion but the involved vascular-sensing mechanisms and disease consequences remain unclear. We experimentally investigated transgenic mice and performed genetic studies in a UK-based human cohort. We show that endothelial cells express the putative HCO<sub>3</sub><sup>-</sup>-sensor receptor-type tyrosine-protein phosphatase RPTPγ, which enhances endothelial intracellular Ca<sup>2+</sup>-responses in resistance arteries and facilitates endothelium-dependent vasorelaxation only when CO<sub>2</sub>/HCO<sub>3</sub><sup>-</sup> is present. Consistent with waning RPTPγ-dependent vasorelaxation at low [HCO<sub>3</sub><sup>-</sup>], RPTPγ limits increases in cerebral perfusion during neuronal activity and augments decreases in cerebral perfusion during hyperventilation. RPTPγ does not influence resting blood pressure but amplifies hyperventilation-induced blood pressure elevations. Loss-of-function variants in <i>PTPRG</i>, encoding RPTPγ, are associated with increased risk of cerebral infarction, heart attack, and reduced cardiac ejection fraction. We conclude that <i>PTPRG</i> is an ischemia susceptibility locus; and RPTPγ-dependent sensing of HCO<sub>3</sub><sup>-</sup> adjusts endothelium-mediated vasorelaxation, microvascular perfusion, and blood pressure during acid-base disturbances and altered tissue metabolism.
Medical subject headings
- Ischemia
- Receptor-Like Protein Tyrosine Phosphatases, Class 5